Skip to main content
Top

Drugs

Issue 11/2023

Content (11 Articles)

Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?

Mario Cazzola, Paola Rogliani, Maria Gabriella Matera

Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review

Francesco Venuti, Mattia Trunfio, Anne-Grete Martson, Filippo Lipani, Sabrina Audagnotto, Giovanni Di Perri, Andrea Calcagno

Focus on Metformin: Its Role and Safety in Pregnancy and Beyond

Christine Newman, Louise Rabbitt, Adesuwa Ero, Fidelma P. Dunne

Effectiveness of Non-Budesonide Therapies in Management of Microscopic Colitis: A Systematic Review and Meta-analysis

Amalie Rehde, Sebastian Kjærgaard Hendel, Carsten Bogh Juhl, John Gubatan, Ole Haagen Nielsen

Tofersen: First Approval

Hannah A. Blair

Mirikizumab: First Approval

Susan J. Keam

Concizumab: First Approval

Susan J. Keam

Correction to: Lenacapavir: First Approval

Julia Paik

Correction to: Zavegepant: First Approval

  • Open Access
  • Correction

Sohita Dhillon

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images